Toward a consensus on endoscopic surveillance of patients with colonic inflammatory bowel disease

Gastrointestinal Endoscopy Clinics of North America

Volumn 24, Issue 3, 2014, Pages 469-481

  Shergill, Amandeep K ^a   Farraye, Francis A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

Chromoendoscopy; Colitis surveillance; Colonoscopy; IBD associated colorectal cancer; IBD associated colorectal neoplasia

Indexed keywords

CANCER SCREENING; CHROMOENDOSCOPY; COLON DISEASE; COLON DYSPLASIA; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL TUMOR; CROHN COLITIS; CROHN DISEASE; DYSPLASIA; ENDOSCOPIC SURGERY; HUMAN; INFLAMMATORY BOWEL DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING; ULCERATIVE COLITIS; COLON; COLORECTAL NEOPLASMS; COMPLICATION; CONSENSUS; EARLY DIAGNOSIS; PATHOLOGY; PRECANCEROUS CONDITIONS; PROCEDURES;

COLON; COLONOSCOPY; COLORECTAL NEOPLASMS; CONSENSUS; EARLY DETECTION OF CANCER; HUMANS; INFLAMMATORY BOWEL DISEASES; PRACTICE GUIDELINES AS TOPIC; PRECANCEROUS CONDITIONS;

EID: 84903447021     PISSN: 10525157     EISSN: 15581950     Source Type: Journal    
DOI: 10.1016/j.giec.2014.03.006     Document Type: Review

References (50)

1. Cairns S.R., Scholefield J.H., Steele R.J., et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010, 59:666-689.
2. Farraye F.A., Odze R.D., Eaden J., et al. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010, 138:746-774. 74.e1-4; [quiz: e12-3].
3. Itzkowitz S.H., Present D.H. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:314-321.
4. Kornbluth A., Sachar D.B. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010, 105:501-523. [quiz: 24].
5. Leighton J.A., Shen B., Baron T.H., et al. ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc 2006, 63:558-565.
6. National Institute for Health and Clinical Excellence. Colonoscopic Surveillance for Prevention of Colorectal Cancer in People with Ulcerative Colitis, Crohn's Disease or Adenomas. Clinical Guidelines, No. 118. London 2011.
7. Van Assche G., Dignass A., Bokemeyer B., et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. JCrohn's Colitis 2012, 7:1-33.
8. Cancer Council Australia Colonoscopy Surveillance Working Party Clinical Practice Guidelines for Surveillance Colonoscopy - in adenoma follow-up; following curative resection of colorectal cancer; and for cancer surveillance in inflammatory bowel disease December, 2011, 48-62. Cancer Council Australia, Sydney, Australia.
9. Rutter M.D., Riddell R.H. Colorectal dysplasia in inflammatory bowel disease: a clinicopathologic perspective. Clin Gastroenterol Hepatol 2013, 12:359-367.
10. Choi P.M., Nugent F.W., Schoetz D.J., et al. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993, 105:418-424.
11. Eaden J., Abrams K., Ekbom A., et al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 2000, 14:145-153.
12. Karlen P., Kornfeld D., Brostrom O., et al. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 1998, 42:711-714.
13. Lashner B.A., Kane S.V., Hanauer S.B. Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol 1990, 85:1083-1087.
14. Lutgens M.W., Oldenburg B., Siersema P.D., et al. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer 2009, 101:1671-1675.
15. Collins P.D., Mpofu C., Watson A.J., et al. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2006, (2). CD000279.
16. New Zealand Guidelines Group Guidance on surveillance for people at increased risk of colorectal cancer 2011 2011, New Zealand Guidelines Group, Wellington (New Zealand).
17. Rufo P.A., Denson L.A., Sylvester F.A., et al. Health supervision in the management of children and adolescents with IBD: NASPGHAN recommendations. JPediatr Gastroenterol Nutr 2012, 55:93-108.
18. Annese V., Daperno M., Rutter M.D., et al. European evidence based consensus for endoscopy in inflammatory bowel disease. JCrohn's Colitis 2013, 7:982-1018.
19. Lichtenstein G.R., Hanauer S.B., Sandborn W.J., Practice Parameters Committee of American College of Gastroenterology Management of Crohn's disease in adults. Am J Gastroenterol 2009, 104:465-483. [quiz: 464, 484].
20. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535.
21. Rutter M.D., Saunders B.P., Wilkinson K.H., et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006, 130:1030-1038.
22. Lutgens M.W., Vleggaar F.P., Schipper M.E., et al. High frequency of early colorectal cancer in inflammatory bowel disease. Gut 2008, 57:1246-1251.
23. Baars J.E., Kuipers E.J., van Haastert M., et al. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey. JGastroenterol 2012, 47:1308-1322.
24. Beaugerie L., Svrcek M., Seksik P., et al. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology 2013, 145:166-175.e8.
25. Jess T., Rungoe C., Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 2012, 10:639-645.
26. Soetikno R.M., Lin O.S., Heidenreich P.A., et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 2002, 56:48-54.
27. Ekbom A., Helmick C., Zack M., et al. Ulcerative colitis and colorectal cancer. A population-based study. NEngl J Med 1990, 323:1228-1233.
28. Soderlund S., Brandt L., Lapidus A., et al. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology 2009, 136:1561-1567. [quiz: 1818-9].
29. Rutter M., Saunders B., Wilkinson K., et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004, 126:451-459.
30. Rubin D.T., Huo D., Kinnucan J.A., et al. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. Clin Gastroenterol Hepatol 2013, 11:1601-1608.e4.
31. Gupta R.B., Harpaz N., Itzkowitz S., et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007, 133:1099-1105. [quiz: 340-1].
32. Askling J., Dickman P.W., Karlen P., et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 2001, 120:1356-1362.
33. Thomas T., Abrams K.A., Robinson R.J., et al. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther 2007, 25:657-668.
34. Rutter M.D., Saunders B.P., Wilkinson K.H., et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 2004, 53:1813-1816.
35. Rubin C.E., Haggitt R.C., Burmer G.C., et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992, 103:1611-1620.
36. Blonski W., Kundu R., Lewis J., et al. Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis?. Scand J Gastroenterol 2008, 43:698-703.
37. Rubin D.T., Rothe J.A., Hetzel J.T., et al. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?. Gastrointest Endosc 2007, 65:998-1004.
38. Rutter M.D., Saunders B.P., Wilkinson K.H., et al. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 2004, 60:334-339.
39. van den Broek F.J., Stokkers P.C., Reitsma J.B., et al. Random biopsies taken during colonoscopic surveillance of patients with longstanding ulcerative colitis: low yield and absence of clinical consequences. Am J Gastroenterol 2011, [Epub ahead of print].
40. Soetikno R., Subramanian V., Kaltenbach T., et al. The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease. Gastroenterology 2013, 144:1349-1352. 1352.e1-6.
41. East J.E. Colonoscopic cancer surveillance in inflammatory bowel disease: what's new beyond random biopsy?. Clin Endosc 2012, 45:274-277.
42. Murthy S.K., Kiesslich R. Evolving endoscopic strategies for detection and treatment of neoplastic lesions in inflammatory bowel disease. Gastrointest Endosc 2013, 77:351-359.
43. Committee ASoP, Sharaf R.N., Shergill A.K., et al. Endoscopic mucosal tissue sampling. Gastrointest Endosc 2013, 78:216-224.
44. Hurlstone D.P., Sanders D.S., Atkinson R., et al. Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm?. Gut 2007, 56:838-846.
45. Smith L.A., Baraza W., Tiffin N., et al. Endoscopic resection of adenoma-like mass in chronic ulcerative colitis using a combined endoscopic mucosal resection and cap assisted submucosal dissection technique. Inflamm Bowel Dis 2008, 14:1380-1386.
46. Kiesslich R., Fritsch J., Holtmann M., et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003, 124:880-888.
47. Kudo S., Rubio C.A., Teixeira C.R., et al. Pit pattern in colorectal neoplasia: endoscopic magnifying view. Endoscopy 2001, 33:367-373.
48. Hata K., Watanabe T., Motoi T., et al. Pitfalls of pit pattern diagnosis in ulcerative colitis-associated dysplasia. Gastroenterology 2004, 126:374-376.
49. Thorlacius H., Toth E. Role of chromoendoscopy in colon cancer surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2007, 13:911-917.
50. Wanders L.K., Dekker E., Pullens B., et al. Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis. Clin Gastroenterol Hepatol 2014, 12:756-764.